Goodman Noah — SEC Form 4 filings
SEC reporting owner CIK 2060075. 7 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2025-04-09 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 5 filings — 22,500 shares, $2,223,841 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 3,389 shares @ $114.29 ($387,329) in Kymera Therapeutics, Inc., filed 2026-07-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | Chief Business Officer | 7 | — | 9 legs · 22,500 sh · $2,223,841 | 10 |
Form 4 filings — Goodman Noah
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-02 | 4 | Kymera Therapeutics, Inc. (KYMR) | Sale (S): 3,389 @ $114.29 | EDGAR |
| 2026-06-25 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 5,000 @ $21.05 · Sale (S): 2,500 @ $109 · Sale (S): 2,500 @ $119 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 2,500 @ $21.05 · Sale (S): 2,500 @ $99 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2026-04-16 | 4 | Kymera Therapeutics, Inc. (KYMR) | Sale (S): 1,347 @ $90 | EDGAR |
| 2026-04-10 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 2,500 @ $21.05 · Sale (S): 3,094 @ $86.62 · Sale (S): 2,670 @ $87.11 · Sale (S): 2,500 @ $89 · Sale (S): 2,000 @ $87.35 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 9,225 @ $0 · Grant/award (A): 18,450 (derivative) @ $0 | EDGAR |
| 2025-04-09 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2060075 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →